Effect of trigger day serum luteinising hormone levels on the in-vitro fertilization outcome: an observational study

被引:0
作者
Kaur, Harpreet [1 ]
Pranesh, Gautham [2 ]
Rao, Vyshnavi [3 ]
Rao, Kamini A. [4 ]
机构
[1] All India Inst Med Sci, Dept Obstet & Gynaecol, Bilaspur 174001, Delhi, India
[2] Milann Fertil Ctr, Biochem, Bangalore, India
[3] Milann Fertil Ctr, Reprod Med, Bangalore, India
[4] Medline Acad, Dept Reprod Med, Bangalore, India
关键词
In-vitro fertilization; Luteinising hormone; Mature ova; Pregnancy outcome; FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; FINAL OOCYTE MATURATION; GNRH ANTAGONIST; OVARIAN STIMULATION; AGONIST; WOMEN; RISK;
D O I
10.5468/ogs.23215
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective Controlled ovarian stimulation leads to profound changes in the endocrine characteristics of the ovarian cycle. Serum luteinising hormone (LH) levels on the day of trigger have been shown to correlate with oocyte quality and pregnancy rate in antagonist cycles. Methods This is an observational study of 86 women undergoing an antagonist in -vitro fertilisation cycle. Oocyte maturation trigger used was either Inj. human chorionic gonadotropin or Inj. triptorelin 0.2 mg s/c or a combination of both. Women were categorised into four groups based on serum LH levels on the day of trigger i.e., LH <= 0.5 (n=8), LH=0.61.0 international units (IU)/L (n=12), LH=1.0-1.5 IU/L (n=13), and LH >1.6 IU/L (n=53) and the subgroup analysis was done based on type of trigger used. Results Mature oocyte (MII) retrieval rate did not show a significant relation with serum LH levels (87%, 89%, 77%, and 76% in groups with LH <0.5, 0.5-1.0, 1.0-1.5, and >1.5 IU/L respectively; P-value=0.243). There was no significant difference in the clinical pregnancy rate either when women were split according to the type of trigger given or according to trigger day LH levels. Women with low LH levels (<0.5 IU/L) required significantly more doses of gonadotropins compared to women with LH levels of 1.0-1.5 IU/L. (3,531+1,133 vs. 2,281+938; P-value=0.01). Conclusion Based on the observation from the current study, there was no significant association of serum LH levels with MII retrieval rate and clinical pregnancy rate. The group with low LH levels required slightly longer days of stimulation.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 23 条
[1]   GnRH antagonist in assisted reproduction: a Cochrane review [J].
Al-Inany, H ;
Aboulghar, M .
HUMAN REPRODUCTION, 2002, 17 (04) :874-885
[2]   Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment [J].
Beckers, NGM ;
Macklon, NS ;
Eijkemans, MJ ;
Ludwig, M ;
Felberbaum, RE ;
Diedrich, K ;
Bustion, S ;
Loumaye, E ;
Fauser, BCJM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4186-4192
[3]   Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer [J].
Benmachiche, Abdelhamid ;
Benbouhedja, Sebti ;
Zoghmar, Abdelali ;
Humaidan, Peter .
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[4]   Follicular Phase Endocrine Characteristics during Ovarian Stimulation and GnRH Antagonist Cotreatment for IVF: RCT Comparing recFSH Initiated on Cycle Day 2 or 5 [J].
Blockeel, Christophe ;
Sterrenburg, Monique D. ;
Broekmans, Frank J. ;
Eijkemans, Marinus J. C. ;
Smitz, Johan ;
Devroey, Paul ;
Fauser, Bart C. J. M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :1122-1128
[5]   Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol [J].
Chen, Shi-Ling ;
Ye, De-Sheng ;
Chen, Xin ;
Yang, Xin-Hong ;
Zheng, Hai-Yan ;
Tang, Yan ;
He, Yu-Xia ;
Guo, Wei .
HUMAN REPRODUCTION, 2012, 27 (05) :1351-1356
[6]   Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol [J].
Griesinger, G ;
Dawson, A ;
Schultze-Mosgau, A ;
Finas, D ;
Diedrich, K ;
Felberbaum, R .
FERTILITY AND STERILITY, 2006, 85 (03) :791-793
[7]   Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination [J].
Halim, Binarwan ;
Lubis, Hilma Putri .
OBSTETRICS & GYNECOLOGY SCIENCE, 2022, 65 (02) :207-214
[8]   Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization [J].
Kuang, Yanping ;
Chen, Qiuju ;
Fu, Yonglun ;
Wang, Yun ;
Hong, Qingqing ;
Lyu, Qifeng ;
Ai, Ai ;
Shoham, Zeev .
FERTILITY AND STERILITY, 2015, 104 (01) :62-+
[9]   Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist [J].
Kummer, Nicole ;
Benadiva, Claudio ;
Feinn, Richard ;
Mann, Jessica ;
Nulsen, John ;
Engmann, Lawrence .
FERTILITY AND STERILITY, 2011, 96 (01) :63-68
[10]  
Lin YC, 2003, J ASSIST REPROD GEN, V20, P506, DOI 10.1023/B:JARG.0000013651.37866.0c